Author

Mariarosaria Del Sorbo

Observed names: M. Del Sorbo, Mariarosaria del Sorbo

OpenAlex ID: A5037500779

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

2014 · Leo Swadling, Stefania Capone, et al. · Science Translational Medicine · 354

Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

2015 · Christopher A. Green, Elisa Scarselli, et al. · Science Translational Medicine · 127

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal

2018 · Navin Venkatraman, Birahim Pierre Ndiaye, et al. · The Journal of Infectious Diseases · 81

Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial

2014 · Emma-Jo Hayton, Annie Rose, et al. · PLoS ONE · 73

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates

2015 · Angiolo Pierantoni, Maria Luisa Esposito, et al. · Molecular Therapy — Methods & Clinical Development · 60

Chronic hepatitis C viral infection subverts vaccine‐induced T‐cell immunity in humans

2015 · Christabel Kelly, Leo Swadling, et al. · Hepatology · 55

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection

2016 · Leo Swadling, John Halliday, et al. · Vaccines · 41

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection

2019 · Felicity Hartnell, Anthony Brown, et al. · Frontiers in Immunology · 36

Fusion of HCV Nonstructural Antigen to MHC Class II–associated Invariant Chain Enhances T-cell Responses Induced by Vectored Vaccines in Nonhuman Primates

2014 · Stefania Capone, Mariarosaria Naddeo, et al. · Molecular Therapy · 36

MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans

2020 · Ilaria Esposito, Paola Cicconi, et al. · Science Translational Medicine · 35

Optimising T cell (re)boosting strategies for adenoviral and modified vaccinia Ankara vaccine regimens in humans

2020 · Stefania Capone, Anthony Brown, et al. · npj Vaccines · 25

Hepatitis C Virus-Multispecific T-Cell Responses without Viremia or Seroconversion among Egyptian Health Care Workers at High Risk of Infection

2012 · Sayed F. Abdelwahab, Zainab Zakaria, et al. · Clinical and Vaccine Immunology · 19

Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors

2024 · Fulvia Troise, Guido Leoni, et al. · Molecular Therapy Oncology · 5

1004P Initial results from a phase I study of Nous-209, an off-the-shelf viral vectored immunotherapy encoding 209 shared frame shift peptide neoantigens, with pembrolizumab, for the treatment of tumors with a deficiency in mismatch repair/microsatellite instability

2021 · M.J. Overman, G. Leoni, et al. · Annals of Oncology · 4

An Ounce of HCV Prevention

2014 · Leo Swadling, Silvana Capone, et al. · Science Translational Medicine

A highly immunogenic novel genetic vaccine against HCV

2012 · Mariarosaria Del Sorbo, Stefania Capone, et al. · Immunology

Works count: 16

Citation count: 951

H-index: 12

I10-index: 12